» Articles » PMID: 28275562

A Comprehensive Literatures Update of Clinical Researches of Superparamagnetic Resonance Iron Oxide Nanoparticles for Magnetic Resonance Imaging

Overview
Specialty Radiology
Date 2017 Mar 10
PMID 28275562
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

This paper aims to update the clinical researches using superparamagnetic iron oxide (SPIO) nanoparticles as magnetic resonance imaging (MRI) contrast agent published during the past five years. PubMed database was used for literature search, and the search terms were (SPIO OR superparamagnetic iron oxide OR Resovist OR Ferumoxytol OR Ferumoxtran-10) AND (MRI OR magnetic resonance imaging). The literature search results show clinical research on SPIO remains robust, particularly fuelled by the approval of ferumoxytol for intravenously administration. SPIOs have been tested on MR angiography, sentinel lymph node detection, lymph node metastasis evaluation; inflammation evaluation; blood volume measurement; as well as liver imaging. Two experimental SPIOs with unique potentials are also discussed in this review. A curcumin-conjugated SPIO can penetrate brain blood barrier (BBB) and bind to amyloid plaques in Alzheime's disease transgenic mice brain, and thereafter detectable by MRI. Another SPIO was fabricated with a core of Fe3O4 nanoparticle and a shell coating of concentrated hydrophilic polymer brushes and are almost not taken by peripheral macrophages as well as by mononuclear phagocytes and reticuloendothelial system (RES) due to the suppression of non-specific protein binding caused by their stealthy ''brush-afforded'' structure. This SPIO may offer potentials for the applications such as drug targeting and tissue or organ imaging other than liver and lymph nodes.

Citing Articles

Influences of physical stimulations on the migration and differentiation of Schwann cells involved in peripheral nerve repair.

Sun Q, Mu X, Gao Q, Wang J, Hu M, Liu H Cell Adh Migr. 2025; 19(1):2450311.

PMID: 39817348 PMC: 11740713. DOI: 10.1080/19336918.2025.2450311.


Magnetic nanoradiotracers for targeted neutrophil detection in pulmonary arterial hypertension.

Fadon-Padilla L, Miranda-Perez de Alejo C, Miguel-Coello A, Beraza M, Di Silvio D, Urkola-Arsuaga A J Nanobiotechnology. 2024; 22(1):709.

PMID: 39543655 PMC: 11562838. DOI: 10.1186/s12951-024-03000-7.


Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy.

Brewster F, Middleton Z, McWilliam A, Brocklehurst A, Radhakrishna G, Chuter R Clin Transl Radiat Oncol. 2024; 49:100859.

PMID: 39376618 PMC: 11456905. DOI: 10.1016/j.ctro.2024.100859.


Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy.

Jungcharoen P, Thivakorakot K, Thientanukij N, Kosachunhanun N, Vichapattana C, Panaampon J Explor Target Antitumor Ther. 2024; 5(2):316-331.

PMID: 38745773 PMC: 11090691. DOI: 10.37349/etat.2024.00220.


Advancing MRI with magnetic nanoparticles: a comprehensive review of translational research and clinical trials.

Lapusan R, Borlan R, Focsan M Nanoscale Adv. 2024; 6(9):2234-2259.

PMID: 38694462 PMC: 11059564. DOI: 10.1039/d3na01064c.


References
1.
Saito K, Yoshimura N, Saguchi T, Park J, Sugimoto K, Akata S . MR characterization of focal nodular hyperplasia: gadoxetic acid versus superparamagnetic iron oxide imaging. Magn Reson Med Sci. 2012; 11(3):163-9. DOI: 10.2463/mrms.11.163. View

2.
Kim J, Shin J, Cho M . Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch Toxicol. 2011; 86(5):685-700. DOI: 10.1007/s00204-011-0773-3. View

3.
Howarth S, Tang T, Trivedi R, Weerakkody R, U-King-Im J, Gaunt M . Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol. 2008; 70(3):555-60. DOI: 10.1016/j.ejrad.2008.01.047. View

4.
Stuber M, Gilson W, Schar M, Kedziorek D, Hofmann L, Shah S . Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med. 2007; 58(5):1072-7. DOI: 10.1002/mrm.21399. View

5.
Wang Y . Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging. World J Gastroenterol. 2015; 21(47):13400-2. PMC: 4679775. DOI: 10.3748/wjg.v21.i47.13400. View